These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6189497

  • 21. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J, Mortensen BT.
    Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL.
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):411-6. PubMed ID: 18398609
    [Abstract] [Full Text] [Related]

  • 23. Characteristics of cytidine aminohydrolase activity in Trypanosoma cruzi and Crithidia fasciculata.
    Kidder GW.
    J Protozool; 1984 May; 31(2):298-300. PubMed ID: 6381719
    [Abstract] [Full Text] [Related]

  • 24. Transformation and metabolic effects of 5-aza-2'-deoxycytidine in mice.
    Cihak A, Vesely J, Hynie S.
    Biochem Pharmacol; 1980 Nov 01; 29(21):2929-32. PubMed ID: 6161616
    [No Abstract] [Full Text] [Related]

  • 25. Deoxycytidine kinase and cytosine nucleoside deaminase activities in synchronized cultures of normal rat kidney cells.
    Wan CW, Mak TW.
    Cancer Res; 1978 Sep 01; 38(9):2768-72. PubMed ID: 679182
    [Abstract] [Full Text] [Related]

  • 26. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
    Momparler RL, Laliberté J.
    Leuk Res; 1990 Sep 01; 14(9):751-4. PubMed ID: 1700230
    [Abstract] [Full Text] [Related]

  • 27. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P, Beisler JA, Abbasi MM, Wolpert-DeFilippes MK.
    Cancer Res; 1977 Jul 01; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [Abstract] [Full Text] [Related]

  • 28. Chemoprotection against cytosine nucleoside analogs using the human cytidine deaminase gene.
    Eliopoulos N, Beauséjour C, Momparler RL.
    Prog Exp Tumor Res; 1999 Jul 01; 36():124-42. PubMed ID: 10386070
    [No Abstract] [Full Text] [Related]

  • 29. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
    Mancini WR.
    Cancer Chemother Pharmacol; 1992 Jul 01; 30(2):139-44. PubMed ID: 1318170
    [Abstract] [Full Text] [Related]

  • 30. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL.
    Cancer Gene Ther; 2001 Sep 01; 8(9):669-76. PubMed ID: 11593336
    [Abstract] [Full Text] [Related]

  • 31. Dancin' deaminase.
    Harris RS, Matsuo H.
    Nat Struct Mol Biol; 2006 May 01; 13(5):380-1. PubMed ID: 16738602
    [Abstract] [Full Text] [Related]

  • 32. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun 01; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 33. Metabolism of cytosine arabinoside in Tetrahymena pyriformis.
    Benhura MA.
    Comp Biochem Physiol B; 1985 Jun 01; 80(4):821-5. PubMed ID: 3922672
    [Abstract] [Full Text] [Related]

  • 34. Nucleosides. CXIX. Substrate specificity and mechanism of action of cytidine deaminases of monkey plasma and mouse kidney.
    Watanabe KA, Reichman U, Fox JJ, Chou TC.
    Chem Biol Interact; 1981 Oct 01; 37(1-2):41-54. PubMed ID: 7285246
    [No Abstract] [Full Text] [Related]

  • 35. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
    Mejer JN, Mortensen BT, Christensen IJ.
    Med Oncol Tumor Pharmacother; 1990 Oct 01; 7(1):25-9. PubMed ID: 2338846
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
    Bouffard DY, Momparler LF, Momparler RL.
    Anticancer Drugs; 1994 Apr 01; 5(2):223-8. PubMed ID: 7519483
    [Abstract] [Full Text] [Related]

  • 37. Cytidine deaminases (from Escherichia coli and human liver).
    Wentworth DF, Wolfenden R.
    Methods Enzymol; 1978 Apr 01; 51():401-7. PubMed ID: 357900
    [No Abstract] [Full Text] [Related]

  • 38. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL, Momparler LF.
    Cancer Chemother Pharmacol; 1989 Apr 01; 25(1):51-4. PubMed ID: 2480188
    [Abstract] [Full Text] [Related]

  • 39. Alterations in differentiation and pyrimidine pathway enzymes in 5-azacytidine resistant variants of a myoblast line.
    Ng SK, Rogers J, Sanwal BD.
    J Cell Physiol; 1977 Feb 01; 90(2):361-47. PubMed ID: 65357
    [Abstract] [Full Text] [Related]

  • 40. Enzymatic studies on possible improvement of cytosine arabinoside treatment.
    Mejer J.
    Scand J Clin Lab Invest; 1981 Feb 01; 41(1):29-34. PubMed ID: 6942484
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.